FI814172A7 - Ihmisen proinsuliini ja sen kanssa analogisia yhdisteitä sekä menetelmä niiden valmistamiseksi mikrobiselpolypeptidi- ekspressoinnilla ja niiden muuttaminen ihmisen insuliinikinsuliiniksi. - Google Patents

Ihmisen proinsuliini ja sen kanssa analogisia yhdisteitä sekä menetelmä niiden valmistamiseksi mikrobiselpolypeptidi- ekspressoinnilla ja niiden muuttaminen ihmisen insuliinikinsuliiniksi. Download PDF

Info

Publication number
FI814172A7
FI814172A7 FI814172A FI814172A FI814172A7 FI 814172 A7 FI814172 A7 FI 814172A7 FI 814172 A FI814172 A FI 814172A FI 814172 A FI814172 A FI 814172A FI 814172 A7 FI814172 A7 FI 814172A7
Authority
FI
Finland
Prior art keywords
human
conversion
preparation
polypeptide expression
microbial polypeptide
Prior art date
Application number
FI814172A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI814172L (fi
Inventor
David Van Norman Goeddel
Keiichi Itakura
Dennis F Kleid
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI814172L publication Critical patent/FI814172L/fi
Publication of FI814172A7 publication Critical patent/FI814172A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI814172A 1981-01-02 1981-12-28 Ihmisen proinsuliini ja sen kanssa analogisia yhdisteitä sekä menetelmä niiden valmistamiseksi mikrobiselpolypeptidi- ekspressoinnilla ja niiden muuttaminen ihmisen insuliinikinsuliiniksi. FI814172A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02

Publications (2)

Publication Number Publication Date
FI814172L FI814172L (fi) 1982-07-03
FI814172A7 true FI814172A7 (fi) 1982-07-03

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814172A FI814172A7 (fi) 1981-01-02 1981-12-28 Ihmisen proinsuliini ja sen kanssa analogisia yhdisteitä sekä menetelmä niiden valmistamiseksi mikrobiselpolypeptidi- ekspressoinnilla ja niiden muuttaminen ihmisen insuliinikinsuliiniksi.

Country Status (12)

Country Link
EP (1) EP0055945A3 (OSRAM)
JP (1) JPS57163352A (OSRAM)
KR (1) KR830007828A (OSRAM)
AU (1) AU7914581A (OSRAM)
DK (1) DK582481A (OSRAM)
ES (1) ES508446A0 (OSRAM)
FI (1) FI814172A7 (OSRAM)
GR (1) GR78327B (OSRAM)
IL (1) IL64634A (OSRAM)
NZ (1) NZ199391A (OSRAM)
PH (1) PH20660A (OSRAM)
ZA (1) ZA818953B (OSRAM)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
EP0090433A1 (en) * 1982-03-31 1983-10-05 Genetics Institute, Inc. Creation of DNA sequences encoding modified proinsulin precursors
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
JP2857684B2 (ja) * 1989-05-04 1999-02-17 ジェネンテク，インコーポレイテッド ヒトリラキシンの単離のための方法および組成物
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
ATE148710T1 (de) 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
AU765574B2 (en) 1998-03-31 2003-09-25 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
RU2144957C1 (ru) * 1999-02-26 2000-01-27 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pPINS07, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
HUP0301640A2 (hu) * 1999-12-29 2003-08-28 Novo Nordisk A/S. Eljárás élesztőben javított fermentációs hozammal rendelkező inzulin prekurzorok és inzulin prekurzor analógok előállítására
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
JP4992029B2 (ja) 2003-01-31 2012-08-08 エム・エス・ディー・オス・ベー・フェー 無酸素条件でのタンパク質の単離方法
JP2009508470A (ja) 2005-07-21 2009-03-05 アボット・ラボラトリーズ Ｓｏｒｆ構築物並びにポリタンパク質、プロタンパク質及びタンパク質分解による方法を含む複数の遺伝子発現
MX2008003362A (es) 2005-09-14 2008-03-25 Sanofi Aventis Deutschland Escision de precursores de insulinas mediante una variante de tripsina.
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
AU2008327513B2 (en) 2007-09-21 2012-05-03 Cadila Healthcare Limited GCSF fusion protein systems suitable for high expression of peptides
KR101775000B1 (ko) 2009-06-26 2017-09-04 노보 노르디스크 에이/에스 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
CN103328006A (zh) 2010-12-14 2013-09-25 诺沃—诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
PL2739646T3 (pl) 2011-05-10 2018-05-30 Stefan Hermann Kompleksowy układ buforowy do renaturacji ludzkiej proinsuliny lub pochodnych proinsuliny
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
EP3845240B1 (en) 2018-09-12 2024-11-06 Amphastar Nanjing Pharmaceuticals, Inc. Pro-insulin aspart structure and method for preparing insulin aspart
BR112022013009A2 (pt) 2019-12-30 2022-09-06 Gan & Lee Pharmaceuticals Co Ltd Derivados de insulina, composição farmacêutica, uso do derivado da insulina e métodos para tratar ou prevenir diabetes, para aumentar a capacidade de um derivado de insulina e para aumentar a potência de um derivado de insulina
JP2023510218A (ja) 2019-12-30 2023-03-13 ガン アンド リー ファーマスゥーティカルズ カンパニー リミテッド 長時間作用型ｇｌｐ－１化合物
US20250340610A1 (en) 2022-01-28 2025-11-06 Gan & Lee Pharmaceuticals Co., Ltd. Acylated insulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47891B1 (en) * 1977-11-08 1984-07-11 Genentech Inc Plasmid suitable for transformation of a bacterial host to render it capable of polypeptide expression
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
GR71912B (OSRAM) * 1978-08-11 1983-08-16 Univ California
GR70279B (OSRAM) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers

Also Published As

Publication number Publication date
IL64634A (en) 1986-03-31
FI814172L (fi) 1982-07-03
KR830007828A (ko) 1983-11-07
ZA818953B (en) 1983-02-23
EP0055945A3 (en) 1982-09-15
EP0055945A2 (en) 1982-07-14
AU7914581A (en) 1982-07-08
GR78327B (OSRAM) 1984-09-26
JPS57163352A (en) 1982-10-07
ES8401777A1 (es) 1984-01-01
NZ199391A (en) 1985-12-13
ES508446A0 (es) 1984-01-01
IL64634A0 (en) 1982-03-31
PH20660A (en) 1987-03-23
DK582481A (da) 1982-08-13

Similar Documents

Publication Publication Date Title
FI814172A7 (fi) Ihmisen proinsuliini ja sen kanssa analogisia yhdisteitä sekä menetelmä niiden valmistamiseksi mikrobiselpolypeptidi- ekspressoinnilla ja niiden muuttaminen ihmisen insuliinikinsuliiniksi.
IT8223990A0 (it) Preparazioni di insulina stabilizzate e un procedimento per la loro preparazione.
FI830776A7 (fi) Uudet yhdisteet, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineena.
FI824419A7 (fi) Sykliset oktapeptidit ja niiden farmaseuttiset valmisteet, sekä menetelmä niiden valmistamiseksi ja niniiden käyttö.
NO874347L (no) Fremgangsmaate for fremstilling av insulin.
FI820178A7 (fi) Fosforyyliyhdisteet, menetelmä niiden valmistamiseksi, näitä yhdisteitä sisältävät farmaseuttiset valmisteetja niiden käyttö.
FI822248A7 (fi) Uusi hyönteistenvastainen koostumus, menetelmä sen valmistamiseksi ja sen käyttö.
ES514845A0 (es) "un procedimiento para preparar insulina humana o derivados de treomina b30 de insulina humana".
IT7920764A0 (it) Procedimento per preparare pastiglie contenenti acido 1,4-diidro-1-etil-6-fluoro-4-osso-7-(1-piperazino)chinolin-3-carbossilico.
FI803202A7 (fi) Fosfonohydroksietikkahappo, sen valmistusmenetelmä sekä käyttö lääkeaineena.
FI823199A7 (fi) -laktaami-antibiootteja, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
FI812190A7 (fi) Uusia pentapeptidejä, menetelmä niiden valmistamiseksi, farmaseuttisia koostumuksia jotka sisältävät mainittupentapeptidejä ja niiden käyttö.
FI814175A7 (fi) Tiatsoliinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuperustuvia farmaseuttisia valmisteita.
FI91484B (fi) Menetelmä uuden solun kasvua säätelevän tekijän, onkostatiini M:n valmistamiseksi
FI820327A7 (fi) Uusia prostasykliinijohdannaisia, niiden valmistusmenetelmä ja niiden käyttö lääkeaineina.
FI822247A7 (fi) Uusi sientenvastainen koostumus, menetelmä sen valmistamiseksi ja sen käyttö.
IT8223019A0 (it) Formulazioni farmaceutiche a basedi proinsulina umana.
FI831890A7 (fi) Uusia karbasykliiniestereitä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina.
FI822250A7 (fi) Uusi punkkienvastainen koostumus, menetelmä sen valmistamiseksi ja sen käyttö.
FI824030A7 (fi) Uudet peptidit ja menetelmä niiden valmistamiseksi.
FI821248A7 (fi) Uudet prostaglandiinit ja prostasykliinit, menetelmä niiden valmistamiseksi ja niiden käyttö läälääkeianeina.
IT8223018A0 (it) Formulazioni farmaceutiche comprendenti insulina, c-peptide e pro-insulina umani.
FI810710A7 (fi) Homositruunahapon oligoribosidijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö hammasmädän ehkäisemiseksi.
FI861073A7 (fi) Menetelmä guanidiinien, kuten linogliridin, valmistamiseksi sekä menetelmä välituotteiden valmistamiseksi.
FI822586A7 (fi) Oksotienobentsoksepiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GENENTECH, INC.